Alzamend Neuro, Inc.
ALZN · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,001 | -$2,703 | -$1,139 | -$986 |
| Dep. & Amort. | $28 | $28 | $13 | $13 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $32 | $43 | $81 | $81 |
| Change in WC | $0 | $269 | $357 | -$532 |
| Other Non-Cash | -$230 | $0 | $0 | $0 |
| Operating Cash Flow | -$1,171 | -$2,363 | -$689 | -$1,424 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$210 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$210 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $4,035 | $841 | $689 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$87 |
| Other Fin. Act. | $0 | $0 | $648 | $87 |
| Financing Cash Flow | $0 | $4,035 | $1,489 | $689 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,171 | $1,672 | $591 | -$735 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,621 | $3,949 | $3,358 | $4,093 |
| End Cash | $4,449 | $5,621 | $3,949 | $3,358 |
| Free Cash Flow | -$1,171 | -$2,363 | -$899 | -$1,424 |